GLP-1 Users' diets under the microscope: what are they really eating?
NCT ID NCT07313384
First seen Jan 04, 2026
Summary
This study follows 50 adults who are about to start GLP-1 therapy for obesity or type 2 diabetes. Researchers will track how their eating habits change over 12 weeks using diet quality scores and body weight. The goal is to understand what dietary support people need while on these medications, since current guidance focuses mostly on cutting calories rather than ensuring good nutrition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY (DISORDER) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Prisma Health Weight Management Institute
RECRUITINGGreenville, South Carolina, 29607, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact
-
University South Carolina
ENROLLING_BY_INVITATIONColumbia, South Carolina, 20208, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GLP-1 therapy (a class of medications for obesity or type 2 diabetes)
What this could lead to
If successful, this study could help develop better dietary guidelines and support programs for people taking GLP-1 medications.
What could go wrong
This is a small observational study (50 people) that does not test a new treatment. It only looks at eating habits, so it cannot prove whether any diet changes improve health outcomes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.